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Dietary intake, age, gender, and body mass index were investigated as possible predictors of perﬂuorinated compounds in a study
population from northern Norway (44 women and 16 men). In addition to donating a blood sample, the participants answered
a detailed questionnaire about diet and lifestyle. Perﬂuorooctane sulfonate (PFOS) (29ng/mL), perﬂuorooctanoate (PFOA)
(3.9ng/mL), perﬂuorohexane sulfonate (PFHxS) (0.5ng/mL), perﬂuorononanoate (PFNA) (0.8ng/mL), and perﬂuoroheptane
sulfonate (PFHpS) (1.1ng/mL) were detected in more than 95% of all samples. Of the dietary items investigated, fruit and
vegetables signiﬁcantly reduced the concentrations of PFOS and PFHpS, whereas fatty ﬁsh to a smaller extent signiﬁcantly
increasedthelevelsofthesamecompounds.MenhadsigniﬁcantlyhigherconcentrationsofPFOS,PFOA,PFHxS,andPFHpSthan
women. There were signiﬁcant diﬀerences in PFOS isomer pattern between genders, with women having the largest proportion of
linear PFOS. PFOS, PFHxS, and PFHpS concentrations also increased with age.
Copyright © 2009 Charlotta Rylander et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
As a result of many years of production and use in industry
and consumer products, perﬂuorinated compounds (PFCs)
are frequently found in the environment as well as in human
blood world wide [1–4]. Due to their unique properties
to repel both water and oil, PFCs have been important
componentsofsurfaceprotectantsfordiﬀerentmaterialsand
in ﬁre-ﬁghting foams and chemicals [5]. The predominant
PFC in human samples is perﬂuorooctane sulfonate (PFOS),
although other frequently detected compounds are perﬂu-
orooctanoate (PFOA), perﬂuorohexane sulfonate (PFHxS),
and perﬂuorononanoate (PFNA) [1, 3]. In Norway, PFOS
has mainly been used as a component in ﬁre-ﬁghting foams
on oil rigs, although there is no information available
about the use of PFHxS or PFOA [6]. Perﬂuorocarboxylates
(PFCAs), for example, PFOA, and perﬂuoroalkyl sulfonates
(PFASs), for example, PFOS, exist as branched and linear
isomers. The linear isomer of PFOS is most common
in technical mixtures and also in human samples [7, 8].
Diﬀerences in proportion of linear PFOS levels between
inhabitants of three diﬀerent countries have been reported
and the authors concluded that this indicated diﬀerent
exposure sources [7]. However, there is limited information
on isomer distribution in humans world wide.
PFOS and PFHxS have been reported to bioaccumulate
and magnify in the food chain [9, 10], even though PFCs
behave diﬀerently from the legacy persistent organic pollu-
tants (POPs) in the environment. A number of toxic eﬀects,
including alterations in fatty acid metabolism, enlargement
of the liver, reduced birth weight, altered growth and
development, and increased mortality in newborns, have
been demonstrated in PFOS- and PFOA-exposed rodents
[11–14]. Epidemiological studies on humans and health
eﬀects of PFCs are so far limited. Occupationally exposed
workers in PFC industries have been studied in relation
to morbidity, bladder cancer, and self-reported medical
conditions [15–17]. No association between exposure and
outcome was found. Several PFCs are found in human cord
blood, indicating that these compounds easily cross the
placental barrier. Results from human studies investigating
the association between birth weight and PFC concentration2 Journal of Environmental and Public Health
Table 1: Study group characteristics.
Total n = 56a (100%) Women n = 41 (73%) Men n = 15 (27%)
Median (range) Median (range) Median (range)
Age (years) 44 (26–60) 44 (26–60) 44 (32–57)
BMI (kg/m2) 25 (18–43) 24 (18–43) 25 (21–33)
Intake of meat (kg/year)b 46 (5.2–119) 42 (5.2–119) 63 (12–83)
Intake of dairy products (kg/year) 65 (40–299) 54 (4.0–299) 138 (8.9–235)
Intake of bread and cereals (kg/year) 48 (14–114) 46 (14–108) 78 (21–114)
Intake of vegetables and fruit (kg/year)c 151 (51–363) 154 (52–363) 136 (51–305)
Intake of fatty ﬁsh (kg/year)d 3.2 (0–39) 3.1 (0–18) 3.4 (0–39)
Intake of lean ﬁsh (kg/year)e 15 (0–63) 14 (0–63) 18 (5.1–38)
Intake of other kinds of ﬁsh (kg/year)f 2.1 (0–19) 2.1 (0–19) 2.1 (0–19)
Intake of ﬁsh products (kg/year)g 15 (1.7–53) 15 (1.7–41) 20 (4.5–53)
Intake of shellﬁsh (kg/year) 0 (0–3.2) 0 (0–3.2) 0 (0–3.2)
aFour people were excluded due to poor chromatography and the total number of study participants was reduced to 56.
bInclude meat and meat products.
cI n c l u d ep o t a t o e s ,v e g e t a b l e s ,j u i c e ,j a m ,a n df r u i t .
dInclude intake of salmon, mackerel, wolﬁsh, and herring.
eInclude intake of boiled and fried cod.
fInclude intake of other kinds of ﬁsh not included in above two categories.
gInclude intake of ﬁsh cakes, ﬁsh au gratin, deep-fried ﬁsh, and ﬁsh spread.
are so far conﬂicting [18, 19]. In 2001, 3M, one of the major
producers of PFOS, voluntarily started to withdraw PFOS
from production due to its persistent and toxic properties in
the environment [20]. By 2015 or earlier, DuPont, which is a
large producer of PFOA, is committed to totally phasing out
PFOA and PFOA production precursors [21].
Even though PFCs have recently received a great deal
of attention, routes of human exposure to PFCs are still
unclear. Diﬀerent pathways have been considered, such as
diet, contaminated drinking water, household dust, and
outdoor and indoor air [22]. Some studies have found
diet to be the major pathway, whereas others suggest that
diet is part of a more complex exposure scenario [22–25].
Five diﬀerent studies have investigated PFC concentrations
in food samples from Germany, Canada, the UK, Spain,
and the Netherlands, and the results deviate [23–27]. None
of the studies detected PFCs in all samples analyzed and
several of them investigated only selected foodstuﬀs, not
the whole diet. The UK food survey found the highest
concentrations of PFOS in potatoes and potato products,
such as french fries, hash browns, and potato salads [26].
The Spanish study [25] reported the highest concentrations
of PFOS in ﬁsh and dairy products whereas the Canadian
study [23] found the highest concentration of PFOS in
beefsteak and salt water ﬁsh. De Voogt et al. reported the
highest PFOS concentrations in beef, cod, and milk [27].
A study on seafood from Chinese ﬁsh markets observed
detectable but low concentrations of PFOS (0.33–13.9ng/g)
in all species investigated, with the highest level in mantis
shrimp [28]. Recently, the National Institute of Nutrition
and Seafood Research in Norway reported low levels of PFCs
in capelin (2–3.5ng/g) and shrimp (<1–10ng/g) and levels
below the limit of detection (LOD) (<3ng/g) in ﬁlets of
farmed salmon [29, 30]. Only a few previous studies have
investigated the relationship between self-reported dietary
intake and plasma concentrations of PFCs [31–33]. Two
of the studies [31, 33] concluded that locally caught ﬁsh
signiﬁcantly increased the body burden of PFOS. The third
study[32]observedapositive associationbetweenPFOSand
PFOA and consumption of red meat, snacks, and animal fat,
and a negative relationship to intake of fruit, vegetables, and
poultry.
The aim of this study was to determine the background
concentrations of PFCs in a Norwegian coastal population in
relation to age, gender, body mass index (BMI), and dietary
habits, with special emphasis on ﬁsh consumption. This
study also adds more information about the PFOS isomer
pattern in human blood samples.
2.MaterialsandMethods
2.1. Study Participants. Study participants were recruited by
an advertisement in the local newspaper through the survey
“UV-light in Northern Norway and D-vitamin production
in skin”, a research project on Andøya Island, described
elsewhere [34]. The people on Andøya are known to have
a high consumption of various kinds of seafood. Criteria
for being included in the study were age between 20 and
60 years and living in the municipality of Andenes at 69
◦N.
The participants were 44 women and 16 men of various ages
(26–60 years) (Table 1). Concentrations of POPs in the same
study group have been reported elsewhere [35].
2.2. Food Frequency Questionnaire. The participants answer-
ed the Norwegian Women and Cancer Study’s (NOWAC)
food frequency questionnaire. Study participants were asked
to record how often they consumed 86 diﬀerent foodstuﬀs
including alcohol. Questions about portion size were also
answered. The questionnaire diﬀerentiates between diﬀerent
kinds of ﬁsh and meat consumed. These variables wereJournal of Environmental and Public Health 3
later grouped together (Table 1). The questionnaire has been
validated and described in detail elsewhere [36, 37].
2.3. Blood Samples. Blood samples were collected in August
toSeptember2005.BloodwasdrawninBDVacutainerblood
collection tubes (BD, NJ, USA) containing EDTA buﬀer
(10.8mg) and mailed overnight to the University of Tromsø.
The samples were centrifuged at 3000rev./min for 15min
and the plasma was collected. Plasma samples were stored
at −80
◦C until analysis.
2.4. Chemical Analysis. Samples were extracted and cleaned
up using a modiﬁed method from Powley et al. [38]. In
short, 0.2g plasma was weighed into a 50mL polypropylene
centrifuge tube (Nalgene, Rochester, NY, USA). Twenty-ﬁve
microliters of 13C4-labeled PFOS and 13C4-labeled PFOA
(0.1ng/μL) (Wellington laboratories, Guelph, ON, Canada)
and 4g methanol (Merck, Darmstadt, Germany) were added
to the test tube as internal standards and extraction solvents.
Samples were extracted for 3 × 10 minutes in an ultrasonic
bath (Branson Ultrasonics BV, Soest, the Netherlands). In
between each extraction, samples were mixed thoroughly
with a vortex mixer (VWR, Wester Chester, PN, USA).
Samples were then centrifuged at 2000rev./min for 5min
using a Jouan A14 centrifuge (Thermo Scientiﬁc, Waltham,
MA, USA). The supernatant was collected before volume
reduction to 1g on a Rapid Vap evaporation unit (Labconco,
Kansas City, MO, USA). The extract was transferred to a
1.5mLmicrocentrifugetube(BrandGMBH,Wertheim,Ger-
many) containing 25mg ENVI-Carb 120/400 (Supelco, PN,
USA) and 50μL glacial acetic acid (KEBOLab, Kalbakken,
Norway). The solution was mixed thoroughly and then cen-
trifuged for 10min at 10000rev./min. The supernatant was
weighedandtransferredtoa1.8mLglasstube,and20μL3,5-
bis(triﬂuoromethyl)phenyl acetic acid (BTPA) (0.1ng/μL)
(Wellington Laboratories, Guelph, ON, Canada) were added
as recovery standard. Before analysis, 100μLe x t r a c tw a s
mixed with 100μL water containing 2mmol/L NH4OAc
(BDH Laboratory Supplies, Leicestershire, England).
PFCs were analyzed using a quadrupole time-of-ﬂight-
mass spectrometer, Q-TOF micro, equipped with a 2777
autosampler and a binary HPLC pump (1525) from Waters
(Milford, MA, USA). The method used is slightly modiﬁed
from that of Berger and Hauk˚ as [39]. Mobile phases con-
sisted of (a) 2mmol/L NH4OAc in water and (b) 2mmol/L
NH4OAc in methanol (Merck, Darmstadt, Germany). Before
analysis, mobile phases were degassed using an ultrasonic
bath (Branson Ultrasonics BV, Soest, the Netherlands). A
50μL sample was injected into an ACE 3 C18 reversed-phase
column, with particle size 3μm and length 150mm (ACT,
Aberdeen, Scotland). The ﬂow rate of the mobile phase was
0.2mL/min. The following gradient settings were applied for
elution of the target analytes from the column: 0min to 50%
B; 0–5min linear gradient to 85% B; 5–10min to 85% B;
10-11min linear gradient to 99% B; 11–20min to 99% B;
20-21min linear gradient to 50% B; 21–28min to 50% B.
The QTOF-MS was operated by the Mass Lynx 4.1 software
in negative electrospray ionization mode (ESI) in the m/z
range 100–725. Settings were optimized before analysis as
follows: capillary voltage, −3kV; sample cone voltage, 50V
(0.5–10.3 min), 35V (0.5–20.0 min), and 20V (10.3–20.0
min); desolvation and source temperature, 350 and 120
◦C,
respectively; nitrogen was used as cone gas at a ﬂow of
20l/min, as nebulizer gas maximum ﬂow, and as desolvation
gas at 600l/min. Target analytes and analytical standards,
their abbreviation, quantiﬁcation masses and cone voltages
are listed in supplementary Table S1 in Supplementary
Material available online at doi:10.1155/2009/268219.
The quantiﬁcation was conducted by the QuanLynx
software, version 3.5 (Waters, Milford, MA, USA).
The linear PFOS isomer was chromatographically sep-
arated from the branched isomers and quantiﬁed, both
separated and as the sum of all isomers. The coelution of
branched isomers (one peak) was not structurally elucidated
but rather identiﬁed as eluting earlier than the linear PFOS,
asindicatedinsupplementaryFigureS1.Isomerspeciﬁcation
was not performed for the other PFCs, where the linear
isomer clearly dominated. Data presented as “PFOS” consist
of the sum of the linear and the coeluted peak of branched
isomers. Similar response factors have been reported for
branched and linear isomers of PFOS [40], so the mass
labeled “internal standard for linear PFOS” was used for
quantiﬁcation of the branched isomer as well.
2.5. Quality Control of Chemical Analysis. The quality of the
analysiswasassuredthroughrepetitiveanalysisofblanksam-
ples and reference samples obtained from previous interna-
tional comparison programs. For each batch of 30 samples,
one reference material and two blank samples were prepared.
Three times a year, the present laboratory also participates
in the AMAP Ringtest for Persistent Organic Pollutants
in Human Serum, an international comparison program,
organized by Institut National de Sant´ e Publique du Qu´ ebec,
Canada. Results from interlaboratory comparisons indicate
that the uncertainties of our analysis are well within ±30%
of the assigned values. Four samples were excluded from all
analysis due to poor chromatography. Therefore, the total
number of study participants was reduced to 56. Recovery
rates varied between 60% and 120%.
The LOD was automatically calculated by the quantiﬁca-
tion software from the signal-to-noise level in each sample.
The individual LODs were comparable for all samples and
an average is reported for each analyte in Table 2.P F O Aw a s
detectedinafewblanksamples.IftheconcentrationofPFOA
in these samples was larger than the software-determined
LOD for that batch of samples, LOD was determined from
the concentration of PFOA in the blanks. All samples were
well within the linear range of the instrument.
2.6. Statistical Analysis. Statistical analysis was performed
using the freely available software R, version 2.8.1 (http://
www.cran.r-project.org/). Statistics for PFOSA, which had
more than 20% of the observations below LOD, were
performedwiththeNADApackageforR.Summarystatistics
for PFOSA were calculated using the maximum likelihood
estimation (MLE) according to Helsel [41]. PFHpA had4 Journal of Environmental and Public Health
Table 2: PFC concentrations (ng/mL) in the study group.
Concentration
(ng/mL plasma)
Total n = 56 Men n = 15 Women n = 41
Median AM Range LOD % >LOD Median AM Range Median AM Range
PFOSA 0.08 0.11 <LOD–0.7 0.03 79 0.11 0.11 <LOD–0.35 0.08 0.10 <LOD–0.71
PFHxS 1.1 1.8 0.40–13 0.07 100 1.8 3.5 0.95–13 0.8 1.2 0.40–3.8
PFHpS 0.46 0.57 <LOD–1.9 0.13 96 0.70 0.89 0.31–1.9 0.35 0.45 <LOD–1.3
PFOS branched 9.4 10 <LOD–31 0.22 96 12 15 <LOD–31 7.1 8.3 <LOD–26
PFOS linear 20 23 4.7–69 0.40 100 24 33 14–69 17 19 4.7–47
PFOS 29 33 6.9–99 43 48 28–99 24 27 6.9–67
PFHpA NA NA NA 0.26 0 NA NA NA NA NA NA
PFOA 3.9 4.4 1.4–9.6 0.30 100 5.1 5.4 3.0–8.8 3.4 4.0 1.4–9.6
PFNA 0.81 0.95 <LOD–2.9 0.26 98 0.94 1.1 0.40–2.9 0.77 0.88 <LOD–2.4
% linear PFOS 69 69 49–100 67 67 49–100 69 70 56–100
AM, arithmetic mean; LOD, method detection limit; % >LOD, percentage of samples in which the analyte was detected; NA, not available; PFOSA,
perﬂuorooctane sulfonic acid; PFHxS, perﬂuorohexane sulfonate; PFHpS, perﬂuoroheptane sulfonate; PFOS, sum of branched and linear isomers of PFOS
(perﬂuorooctane sulfonate); PFHpA, perﬂuoroheptanoate; PFOA, perﬂuorooctanoate; PFNA, perﬂuorononanoate; % linear PFOS, percentage linear PFOS
related to PFOS.
more than 95% of the observations below LOD and were not
evaluated statistically.
Possible predictors of PFC concentrations investigated
were age, gender, BMI, and nine diﬀerent categories of
foodstuﬀ (see Table 1). The impact of these predictors
on PFOS, PFOA, PFHxS, PFHpS, PFNA, and percentage
linear PFOS was investigated using linear models on log-
transformed variables or Wilcoxon’s rank sum test. For the
censored data (PFOSA), the nonparametric Peto-Prentice
test, as well as the nonparametric Akritas-Thiel-Sen slope in
the NADA package for R, was used. The censored methods
are described by Helsel [41]. Model assumptions for the
linear models were evaluated using diagnostic plots of the
residuals. Parameter estimates (β) with 95% conﬁdence
interval and the levels of signiﬁcance (P values) for the ﬁnal
regression models are reported in Table 3. The parameter
estimates (β) are back-transformed logresults and should be
interpreted as the number of times that the response variable
increased/decreased by one unit in explanatory variable.
Wilcoxon’s test estimator (W) and the corresponding P
values are reported in the text. The P values <.05 were
considered to be signiﬁcant.
3. Results
Median, arithmetic mean, range, LOD, and percentage of
samples with values > LOD of the eight monitored PFCs
are provided in Table 2. PFOS, PFOA, PFHxS, PFHpS, and
PFNA were detected in more than 95% of all samples.
PFOS and PFHpS concentrations were strongly cor-
related (r = 0.93) (Figure 1), as well as PFOS and
PFNA (r = 0.70) and PFOSA and PFNA (r = 0.72)
(Figure 1). The remaining PFCs were medium strong or
weakly correlated (supplementary Table S2). There were
four signiﬁcant predictors for PFOS concentration in this
study group: gender, age, intake of fruit and vegetables,
and intake of fatty ﬁsh (Table 3). Men had 75% higher
concentrations of PFOS than those of women and the PFOS
concentration increased by 2% per year of age (for the
whole group) (Table 3). An additional serving (150g) of
fruit and vegetables per day during the last year decreased
the concentrations of PFOS by 16%, whereas an extra meal
(150g) of fatty ﬁsh per week during the last year resulted
in an increase in PFOS concentrations (22%) (Table 3). Age,
gender, consumption of fatty ﬁsh, and consumption of fruit
and vegetables explained 57% of the variation in PFOS
concentration (Table 3). Fatty ﬁsh alone accounted for 4%,
fruitandvegetablesexplained16%,andageandgender37%.
There was no correlation between intake of fatty ﬁsh and
intake of fruit and vegetables (r =− 0.00014).
Male sex was clearly associated with increased plasma
concentrations of PFOA (44%), PFHxS (172%), and PFHpS
(107%) (Table 3). There was a positive relationship between
age and PFHxS and PFHpS, both indicating a 3% increase
in concentrations per year of age (Table 3). An additional
intake of 150g (one serving) of fatty ﬁsh per week, over
the last year, resulted in increased concentrations of PFHpS
(32%), whereas an additional serving (150g) of fruit and
vegetables each day, over the last year, decreased the
concentration of PFHpS by 17% (Table 3). None of the
investigated variables inﬂuenced the concentration of PFNA
or PFOSA signiﬁcantly. Two people were excluded from
the PFOS and PFHpS models because they were strongly
inﬂuential. The results were the same, before and after
exclusion, but the reﬁned models explained more of the
variation in the dataset. Intake frequencies of fatty ﬁsh and
fruit/vegetables, and the corresponding concentrations of
PFOS and PFHpS, are reported in Table S3. The person
who consumed two to three servings of fatty ﬁsh per
week (67ng/mL PFOS, supplementary Table S3) was not
indicatedasanoutlierbythediagnosticplotsoftheresiduals,
although, on removal of that person from the dataset, fatty
ﬁsh were no longer a signiﬁcant predictor (P>. 05) forJournal of Environmental and Public Health 5
Table 3: Back-transformed parameter estimates, 95% conﬁdence interval (CI) and P values for the ﬁnal regression models of selected PFCs
and signiﬁcant predictors.
PFOS PFOA PFHxS PFHpS
β (95% CI) Pβ (95% CI) Pβ (95% CI) Pβ (95% CI) P
Male sex 1.75 (1.43, 2.14) <.001 1.44 (1.12, 1.85) .009 2.72 (1.86, 3.92) <.001 2.07 (1.57, 2.74) <.001
Age (years) 1.02 (1.01, 1.03) <.001 1.01 (0.998, 1.02) .096 1.03 (1.01, 1.03) <.001 1.03 (1.01, 1.04) <.001
Consumption of
fatty ﬁsh (150g per
week during a
year)
1.22 (1.02, 1.45) .029 1.32 (1.03, 1.68) .027
Consumption of
fruit and vegetables
(150g per day
during a year)
−1.16 (−1.08, −1.25) <.001 −1.17 (−1.06, −1.29) .002
R2 (%) 57 17 41 50
β, parameter estimates (back-transformed logresults); R2,c o e ﬃcient of determination, that is, the proportion of variability in the dataset that is explained by
the model; PFOS, perﬂuorooctane sulfonate; PFOA, perﬂuorooctanoate; PFHxS, perﬂuorohexane sulfonate; PFHpS, perﬂuoroheptane sulfonate.
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Figure 1: Correlation between perﬂuorooctane sulfonate (PFOS) and perﬂuorononanoate (PFNA) (r = 0.70) and PFOS and
perﬂuoroheptane sulfonate (PFHpS) (r = 0.93), as well as perﬂuorooctane sulfonic acid (PFOSA) and PFNA (r = 0.72).6 Journal of Environmental and Public Health
PFOS or PFHpS concentrations. The result for fruit and
vegetables, age, and gender remained the same, before and
after exclusion. In the ﬁnal model (Table 3), the person was,
however, included because of the indication of not being an
outlier.
The study group had an average proportion of linear
PFOS of 69% (range 49%–100%) (Table 2). Women had
a signiﬁcantly larger percentage of linear PFOS than that
of men (70% versus 67%, W = 415.5, P = .047). The
proportion of linear PFOS varied between 49% and 100%
for men and between 56% and 100% for women (Table 2).
4. Discussion
We have shown that PFOS and PFHpS concentrations in the
current study decreased with intake of fruit and vegetables
and increased with intake of fatty ﬁsh. An additional serving
of fruit and vegetables (150g) per day, over the last year,
gave an estimated decreased body burden of PFOS and
PFHpS of 16% (95% conﬁdence interval (CI): 8%–25%) and
17% ((CI): 6%–29%), respectively. On the other hand, an
additional meal of fatty ﬁsh per week (150g), over the last
year, resulted in 22% (CI: 2%–45%) and 32% (CI: 3%–68%)
higher concentrations of PFOS and PFHpS, respectively.
Intake of fatty ﬁsh and intake of fruit and vegetables were not
correlatedandtheobservedeﬀectcannotbe explainedbyco-
variation. The maximum intake of fruit and vegetables was
6.6 servings per day and 2.3 servings of fatty ﬁsh per week
(supplementary Table S3). No conclusions outside these
intake ranges can be made from this dataset.
Surprisingly, consumption of fruit and vegetables
decreased PFOS concentrations in the current study. Sup-
porting and contradictory ﬁndings have been reported by
others. Halldorsson et al. [32] found that intake of fruit and
vegetables decreased PFOS and PFOA concentrations in the
Danish Birth cohort (n = 1076), but the eﬀect could be
partly explained by lower intake of red meat, animal fats,
and snacks (positively associated to PFOS) among the high
consumersoffruitandvegetables.Emmetet al.[42]reported
a positive association between locally grown vegetables and
PFOA concentration, whereas Holzer et al. [31]o b s e r v e d
no eﬀect from intake of locally grown fruit and vegetables
on PFOA, PFOS, or PFHxS concentrations in a group of
521 participants. The diﬀerent ﬁndings may reﬂect diﬀerent
study designs and/or presence of confounding factors. In the
Norwegian Women and Cancer Study (NOWAC), dietary
patterns and lifestyle factors were investigated in 35554
Norwegian women [43]. “Healthy eaters” had the highest
intake of fruit, vegetables, skimmed milk, juice, instant
coﬀee, crisp bread, rice, chicken, and cod liver oil, which
is frequently used as a food supplement in Norway. They
were also characterized by high education, high income, few
current smok, and high activity. They were more likely to use
dietarysupplementsthantheotherwomenandmostofthem
lived in the southern or eastern part of Norway. This study
indicates that health awareness is characterized not only by
diet but also by many lifestyle factors. Consequently, our
ﬁndings of decreasing PFOS and PFHpS concentrations with
increasing intake of fruit and vegetables may be explained by
a large number of confounding variables that characterize
the lifestyle of “healthy eaters”, rather than a high fruit and
vegetable intake. It is nevertheless an important ﬁnding that
needs to be investigated further.
In the current study, 20% of the observed variation in
PFOS concentration were explained by intake of fruit and
vegetables(16%)andintakeoffattyﬁsh(4%).Theseﬁndings
support the previous hypothesis that ﬁsh intake contributes
to increased body burdens of PFOS [31, 33]. However,
only one person (67ng/mL, supplementary Table S3) was
responsible for the signiﬁcant association of fatty ﬁsh (P<
.05), and interpretation of this result should therefore be
made with care. In addition, of the participants’ total intake
of seafood, only 9% consisted of fatty ﬁsh. The remaining
91% were intake of lean ﬁsh, ﬁsh products, and other kinds
of ﬁsh that had no impact on PFC concentrations. Thus, the
main source of seafood did not contribute to increased body
burdens of PFOS or PFHpS. The health eﬀects of seafood
consumption have been frequently debated. Beneﬁts from
a ﬁsh-rich diet, for example, lower risk of cardiovascular
diseases, has been weighed up against the possible drawbacks
of increased body burden of environmental pollutants [44].
A substantial increase of one meal of fatty ﬁsh per week over
ayearresultedinonlya22%increaseinPFOSconcentration,
which corresponds to 6ng/mL (from 29ng/mL (median) to
35ng/mL). Furthermore, no associations between a number
of outcomes and occupational exposure to PFCs have been
found in a study group exposed to higher concentrations
than the general population [15–17]. It is therefore unlikely
to expect adverse eﬀects from intake of fatty ﬁsh. The
protective eﬀects of seafood on several health outcomes are
clear and well documented [45] and the beneﬁts of a ﬁsh-
rich diet should by far outweigh the concerns. PFCs are, in
addition,detectedinallkindsoffood[23,25,26,28]andalso
in household dust [46], drinking water [42], and consumer
products [47], indicating that the exposure is complex and
could not be explained just by single foodstuﬀs. This was
also recently pointed out by Halldorsson et al. [32] that
suggested that the overall diet is likely to be more important
for PFC exposure than single foodstuﬀs and results from
individual food groups should therefore be interpreted with
care. K¨ arrman et al. [48] concluded also that the importance
of dietary intake of PFCs may diﬀer between regions.
Fatty ﬁsh and fruit/vegetables were also signiﬁcant
predictors for PFHpS concentrations in this study group.
This ﬁnding is most probably an artifact, explained by
the strong correlation between PFOS and PFHpS (r =
0.93). However, there was a lack of association between the
investigated dietary predictors and plasma concentrations
of PFOA, PFHxS, PFNA, and PFOSA in this study group.
This may point to the diet being a less important pathway
for these compounds due to low concentrations present
in food. The UK food survey detected PFOS in some of
their composite food samples, whereas the concentrations of
PFOA were below LOD (<0.5–10ng/g) in the same samples
[26]. Ericson et al. [25] and Tittlemier et al. [23]d e t e c t e d
PFOS in nearly all of their composite food samples, although
only a few had detectable concentrations of PFOA and/or
PFHpA and PFNA. PFOSA was not found in any of theseJournal of Environmental and Public Health 7
food surveys. Another explanation for the lack of association
between the dietary variables and PFOA, PFHxS, PFNA, and
PFOSA could be the fact that human blood concentrations
of these compounds are lower and more uniform. Also, the
current study had fewer participants, that is, lower chance of
detecting weak eﬀects.
All the investigated PFCs (except for PFOSA versus
PFOA and PFHxS) were medium strong or highly correlated
(supplementary Table S2), with the strongest correlation
being between PFOS and PFHpS (r = 0.93). The correlation
between PFCs seems to vary between countries/studies.
Olsen et al. [49] reported the strongest correlation between
PFOS and PFOA (r = 0.63) in American Red Cross blood
donors. Similar results were provided by Haug et al. [50] that
reported PFOS and PFOA being highly correlated (r = 0.95)
in pooled Norwegian samples. Ericson et al. [51]o b s e r v e d
the strongest correlation between PFOS and PFHxS (r =
0.23) in a study group from Spain while Rylander et al. [52]
reported the strongest correlation between PFOS and PFHxS
(r = 0.94) in delivering women from Vietnam. Diﬀerences
may be attributable to a number of factors, including
diﬀerent sample sizes, age and gender compositions of
the study groups, diﬀerent exposure sources, or analytical
challenges.
Men had signiﬁcantly higher concentrations of PFOS,
PFOA, PFHxS, and PFHpS than those of women in this
study group. Several other studies have reported gender-
related diﬀerences for the same compounds, with men
having higher concentrations than those of women [31,
51, 53–55]. PFOS and PFOA have been found to cross
t h ep l a c e n t a lb a r r i e ra n dh a v eb e e nd e t e c t e di nh u m a n
breast milk, in addition to PFHxS, PFOSA, and PFNA [18,
19, 56–60]. Diﬀerences between genders may therefore be
partly explained by transplacental transfer and excretion
throughbreastfeeding,whichseemlikelyinthisratheryoung
study group. The diﬀerences attributable to childbearing are
expectedtodecreaseovertimeduetocontinuousexposureto
contaminants. Another possible explanation for the gender-
related diﬀerences could be a higher dietary intake among
men. Menopause status, use of contraceptives, and blood
donor practices among the study participants could also
aﬀect the results through the possible blood loss, but this was
not taken into account in the current study. These variables
have, however, not been identiﬁed as confounding factors in
other studies.
Despite the fact that men had higher concentrations of
PFOS than those of women in the current study, female
blood contained a signiﬁcantly larger proportion of linear
PFOS compared with male blood (70% versus 67%). The
major production process of PFOS, electrochemical ﬂuo-
rination (ECF), produced 70%–80% linear PFOS [8]. Our
samples contained on average 69% linear PFOS (range 49%–
100%). This is comparable to results from Sweden (68%,
range 50%–70%) [7] and a previous study in Norway (50%–
78%) [50], but higher than in samples from Australia (59%)
[7] and the UK (60%) [7] and considerably lower than in
samplesfromVietnam(83%)[52].Powleyet al.[38]showed
recently that the proportion of branched PFOS diﬀered
between Arctic cod and ringed seal (which feed on Arctic
cod), indicating diﬀerences in elimination rates between
species.Thus,thedietarycontributionsofPFOSisomersmay
vary between countries/continents due to diﬀerent dietary
habits. Also, the importance of diﬀerent exposure routes,
for example, diet, dust, and consumer products, could
vary between countries. In the current study, the branched
isomers of PFOS were not chromatographically separated
but quantiﬁed as the sum of a mixture of branched isomers.
K¨ arrman et al. [7]a sw e l la sB e n s k i ne ta l .[ 61] identiﬁed
several of the branched isomers of PFOS in human blood,
and both studies indicate that the monoperﬂuoromethyl-
substituted isomers are most abundant in human blood
samples. However, in order to make correct comparisons
of PFOS distribution world wide, it is important to specify
whether linear PFOS or the sum of all PFOS isomers is
reported, especially as the branched isomers may contribute
as much as 30% to the total.
PFOS concentrations in this study group were compara-
ble to samples from Denmark, Sweden, Australia, the USA,
Canada,Poland,Korea,andBelgium,althoughsamplesfrom
Spain, Germany, Colombia, Brazil, Italy, India, Sri Lanka,
Vietnam, and Malaysia were on average up to 20 times less
contaminated [3, 31, 51–53, 62, 63]. Poland, Korea, and
Japan have reported high PFOA concentrations, whereas
studies from China and Spain reported low levels [2, 51, 54].
Our samples were in the midrange. There were smaller
diﬀerences in PFHxS concentrations between countries and
only a few studies reported the concentrations of the other
PFCs. Vietnamese women, for example, had considerable
lower concentrations of PFHpS but comparable levels of
PFNAtothecurrentstudygroup[52].Considerable regional
diﬀerences in PFC concentrations within countries [48, 54]
have also been observed, indicating that a large population-
based study is needed to achieve the full picture of the
exposure pattern within a country.
We observed a positive relationship between age and
PFOS, PFHxS, and PFHpS concentrations. Previous studies
show contradictory results regarding age-related diﬀerences
in PFC concentrations [2, 31, 53], which point to no clear
age trend for the PFCs.
5. Conclusions
Intake of fruit/vegetables and fatty ﬁsh aﬀected the con-
centration of PFOS and PFHpS in this study group. The
reason for the decreased PFOS and PFHpS concentrations
with increased intake of fruit and vegetables has yet to be
explained. A larger population based study is suggested to
evaluatetheeﬀectoffattyﬁshconsumptiononPFOS/PFHpS
concentrations thoroughly since uncertainties were present
in the current study (only one person responsible for the
signiﬁcant eﬀect). Dietary predictors should, however, be
interpreted with care since dietary habits also reﬂect diﬀer-
ences in lifestyle (not adjusted for in the current analysis)
whichmayaﬀectPFCconcentrations.Futureresearchshould
focus on dietary patterns instead of single food groups and
lifestyle factors should also be taken into account. Men had
signiﬁcantly higher concentrations of PFOS, PFOA, PFHxS,
and PFHpS than those of women, and PFOS, PFHxS, and8 Journal of Environmental and Public Health
PFHpS increased with age. Women had a larger proportion
of linear PFOS than those of men (70% versus 67%).
However, the overall average of linear PFOS in this study
group was comparably to previous studies from Sweden
and Norway but considerable higher than in samples from
Vietnam. In future studies the PFOS isomers should be
reported separately in order to help identify diﬀerences
between populations and diﬀerent sources of exposure.
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